The Central Drugs Standard Control Organisation (CDSCO) has started conducting joint inspection of identified Drug Manufacturing Units along with State Drugs Control Administration as per risk based approach. The Press Information Bureau has issued a press release to this effect on 27th December, 2022. These joint inspections are carried out under directions of Union Minister of Health & Family Welfare and Chemicals & Fertilizers.
The Joint Inspections are being conducted all over the country as per the Standard Operating Procedures. A committee of two Joint Drugs Controllers has been constituted at CDSCO (HQ) to monitor the process of inspection, reporting & subsequent action so as to ensure compliance to the Drugs & Cosmetics Act, 1940 and Rules thereunder. The aim is to ensure high standards of quality compliance with respect to drugs manufactured in the country.
An action plan for nationwide inspection of manufacturing units was made prior to carrying out inspections. This was particularly targeted to those manufacturing units which are identified to be at the risk of manufacturing Not of Standard Quality (NSQ)/adulterated/spurious drugs.
